(Q54036841)

English

Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomy.

scientific article published in January 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

author name string

H B Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

G R Betton

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

A L Bowdler

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

R L McFarquhar

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

B J Middleton

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

G Lunglmayr

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

Urological Research

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

22

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

191-195

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine Therapy for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The different mechanisms for suppression of pituitary and testicular function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of antiandrogens and their mechanisms of action: a case study (anandron).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Casodex: a pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7992465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00571849

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

release_wg2q5qbi3zg2lbeowqduagbacm

1 reference

https://api.fatcat.wiki/v0/release/wg2q5qbi3zg2lbeowqduagbacm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/7992465

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54036841&oldid=1842228111"